These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 2686350)
1. The pathogenesis of graft-versus-host reaction in the intrahepatic bile duct. An immunohistochemical study. Tanaka M; Umihara J; Shimmoto K; Cui SJ; Sata H; Ishikawa T; Ishikawa E Acta Pathol Jpn; 1989 Oct; 39(10):648-55. PubMed ID: 2686350 [TBL] [Abstract][Full Text] [Related]
2. Ultrastructural lesions of bile ducts in primary biliary cirrhosis. A comparison with the lesions observed in graft versus host disease. Bernuau D; Feldmann G; Degott C; Gisselbrecht C Hum Pathol; 1981 Sep; 12(9):782-93. PubMed ID: 7030921 [TBL] [Abstract][Full Text] [Related]
3. Intrahepatic bile duct injury following bone marrow transplantation. Analysis of pathological features based on three-dimensional and histochemical observation. Tanaka M; Umihara J; Chiba S; Ishikawa E Acta Pathol Jpn; 1986 Dec; 36(12):1793-806. PubMed ID: 3548212 [TBL] [Abstract][Full Text] [Related]
4. Expression of MHC products by normal and abnormal bile duct epithelium. Van den Oord JJ; Sciot R; Desmet VJ J Hepatol; 1986; 3(3):310-7. PubMed ID: 3549867 [TBL] [Abstract][Full Text] [Related]
5. Participation of natural killer cells in the pathogenesis of bile duct lesions in biliary atresia. Okamura A; Harada K; Nio M; Nakanuma Y J Clin Pathol; 2013 Feb; 66(2):99-108. PubMed ID: 23162109 [TBL] [Abstract][Full Text] [Related]
6. Expression of major histocompatibility complex class II antigens on bile duct epithelium in patients with hepatic graft-versus-host disease after bone marrow transplantation. Miglio F; Pignatelli M; Mazzeo V; Baraldini M; Stefanini GF; Guardigli G; Bandini G; Ricci P; Tura S; Gasbarrini G J Hepatol; 1987 Oct; 5(2):182-9. PubMed ID: 3320179 [TBL] [Abstract][Full Text] [Related]
7. Expression of MHC class II antigens on bile duct epithelium in experimental graft versus host disease. Takács L; Szende B; Rot A; Diamanstein T Clin Exp Immunol; 1985 Jun; 60(3):449-56. PubMed ID: 4040446 [TBL] [Abstract][Full Text] [Related]
8. Vanishing bile duct syndrome after allogeneic bone marrow transplantation: is it the end of the road? Bakanay ŞM; Bilgin AU; Bektaş M; Idilman R; Erden E; Arat M; Arslan Ö Turk J Gastroenterol; 2013; 24(4):359-62. PubMed ID: 24254270 [TBL] [Abstract][Full Text] [Related]
9. Diffuse biliary tract involvement mimicking primary sclerosing cholangitis in an experimental model of chronic graft-versus-host disease in mice. Nonomura A; Kono N; Minato H; Nakanuma Y Pathol Int; 1998 Jun; 48(6):421-7. PubMed ID: 9702853 [TBL] [Abstract][Full Text] [Related]
11. Expression of HLA-DR antigens on bile duct epithelium in primary sclerosing cholangitis. Chapman RW; Kelly PM; Heryet A; Jewell DP; Fleming KA Gut; 1988 Apr; 29(4):422-7. PubMed ID: 3286382 [TBL] [Abstract][Full Text] [Related]
12. Graft-versus-leukaemia following allogeneic bone marrow transplantation: emergence of cytotoxic T lymphocytes reacting to host leukaemia cells. Jiang YZ; Kanfer EJ; Macdonald D; Cullis JO; Goldman JM; Barrett AJ Bone Marrow Transplant; 1991 Oct; 8(4):253-8. PubMed ID: 1756322 [TBL] [Abstract][Full Text] [Related]
13. Graft-versus-leukaemia after bone marrow transplantation. Barret AJ Pediatr Med Chir; 1991; 13(1):9-13. PubMed ID: 2052462 [No Abstract] [Full Text] [Related]
14. Histological changes of the liver in experimental graft-versus-host disease across minor histocompatibility barriers. VIII. Role of eosinophil infiltration. Nonomura A; Kono N; Mizukami Y; Nakanuma Y Liver; 1996 Feb; 16(1):42-7. PubMed ID: 8868077 [TBL] [Abstract][Full Text] [Related]
15. HLA-DR expression in bile duct damage in hepatitis C. Danque PO; Bach N; Schaffner F; Gerber MA; Thung SN Mod Pathol; 1993 May; 6(3):327-32. PubMed ID: 8346181 [TBL] [Abstract][Full Text] [Related]
16. Pathology and pathogenesis of intrahepatic bile duct loss. Nakanuma Y; Tsuneyama K; Harada K J Hepatobiliary Pancreat Surg; 2001; 8(4):303-15. PubMed ID: 11521175 [TBL] [Abstract][Full Text] [Related]
17. HLA-C mismatches induce strong cytotoxic T-cell reactivity in the presence of an additional DRB/DQB mismatch and affect NK cell-mediated alloreactivity. van der Meer A; Allebes WA; Paardekooper J; Ruiter J; Joosten I Transplantation; 2001 Sep; 72(5):923-9. PubMed ID: 11571460 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation. Pei J; Martin PJ; Longton G; Masewicz S; Mickelson E; Petersdorf E; Anasetti C; Hansen J Biol Blood Marrow Transplant; 1997 Aug; 3(3):142-9. PubMed ID: 9310191 [TBL] [Abstract][Full Text] [Related]
19. Marked increase of CD57+CD16- cells in long-term survivors of graft-versus-host disease after allogeneic bone marrow transplantation. Fukuda H; Nakamura H; Tominaga N; Teshima H; Hiraoka A; Shibata H; Masaoka T Jpn J Clin Oncol; 1992 Aug; 22(4):238-43. PubMed ID: 1359173 [TBL] [Abstract][Full Text] [Related]
20. Histological changes of bile duct in experimental graft-versus-host disease across minor histocompatibility barriers. II. Electron microscopic observations. Nonomura A; Kono N; Yoshida K; Nakanuma Y; Ohta G Liver; 1988 Feb; 8(1):32-41. PubMed ID: 3367707 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]